（编辑 姚尧） 证券日报网讯 1月28日，康恩贝在互动平台回答投资者提问时表示，企业"反内卷"的本质在于持续构建 难以替代的核心竞争力。为此，公司系统规划并着力打造四大核心能力：健康领域全链条品牌塑造能 力、前瞻性研发与管线布局能力、全渠道专业合规推广能力、稳定高效供应链能力，以此筑牢发展根基 与竞争壁垒，驱动经济效益与企业价值同步提升。在拓宽营收渠道方面，公司坚持内涵式增长与外延式 扩张双轮驱动。在内涵式增长方面，公司将巩固优势品种品牌如肠炎宁、前列康、至心砃等的领导地 位；挖掘潜力品种如金笛、牛黄上清胶囊、金艾康等系列产品增长机会；洞察市场机会并完善研发布 局，巩固中药大健康的优势并积极布局创新药，寻找新的增长点。在外延式扩张方面，一方面围绕中药 大健康的股权并购，另一方面公司将通过系统化BD快速获取潜力品种，丰富管线。 ...

Core Viewpoint - The company Kang En Bei has a diverse range of products related to influenza and cold treatment, including antiviral, cough relief, pain relief, anti-infection, and health enhancement products, with ongoing development of additional related products [2] Product Categories - Antiviral products include compound Houttuynia cordata granules, blue honeysuckle granules, and Niuhuang Shangqing capsules [2] - Cough relief products consist of acetylcysteine effervescent tablets, compound fresh bamboo liquid, and various syrups and oral liquids for children [2] - Pain relief and cold products feature ibuprofen granules, compound paracetamol and amantadine capsules, and other related formulations [2] - Anti-infection products include amoxicillin capsules and enteric-coated erythromycin tablets [2] - Health enhancement products comprise vitamins and protein powders [2] Recent Developments - The company has recently received approval for a new traditional Chinese medicine, Qinghouyan lozenges, which can alleviate throat discomfort caused by colds [2] - Other influenza and cold-related products are under development, with the Ivy leaf extract and oral liquid project currently in Phase II clinical trials, aimed at treating cough and phlegm associated with acute tracheobronchitis [2]

Core Viewpoint - 康恩贝 (600572.SH) is actively involved in the development and marketing of various medications related to influenza and colds, including antiviral, cough relief, pain relief, anti-infection, and immune-boosting products [1] Product Categories - The company offers antiviral products such as compound Houttuynia cordata granules, blue honeysuckle granules, and Niuhuang Shangqing capsules [1] - Cough relief products include acetylcysteine effervescent tablets, compound fresh bamboo liquid, and various syrups and oral liquids for children [1] - Pain relief and cold medications consist of ibuprofen granules, compound paracetamol and phenylephrine capsules, and other related products [1] - Anti-infection products include amoxicillin capsules and enteric-coated erythromycin tablets [1] - Immune-boosting products feature vitamins and protein powders, along with a newly approved traditional Chinese medicine, Qinghouyan lozenges, for symptomatic relief of throat discomfort caused by colds [1] Research and Development - The company is advancing its research plans for other influenza and cold-related products, with the Ivy leaf extract and oral liquid project currently in Phase II clinical trials, aimed at treating cough and phlegm associated with acute tracheobronchitis [1]

Core Viewpoint - The company 康恩贝 (600572.SH) has a diverse range of products related to influenza and cold treatment, including antiviral, cough relief, pain relief, anti-infection, and immunity-enhancing products [1] Product Categories - Antiviral products include compound Houttuynia cordata granules, Lianqiao granules, and Niuhuang Shangqing capsules [1] - Cough relief products consist of acetylcysteine effervescent tablets, compound fresh bamboo liquid, and various syrups and oral liquids for children [1] - Pain relief and cold products feature ibuprofen granules, compound paracetamol and amantadine capsules, and other related formulations [1] - Anti-infection products include amoxicillin capsules and erythromycin enteric-coated tablets [1] - Immunity-enhancing products comprise vitamins and protein powders, along with a newly approved traditional Chinese medicine for throat discomfort relief [1] Research and Development - The company is advancing its research plans for other influenza and cold-related products, with a project involving ivy leaf extract and oral liquid currently in Phase II clinical trials, aimed at treating cough and phlegm associated with acute tracheobronchitis [1]